“Renaissance Pharma Ltd is a clinical stage biopharmaceutical company focused on improving treatments for rare paediatric diseases. Our lead project aims to establish new antibody-based therapeutics for the treatment of high-risk neuroblastoma.”
Officer details are public data from the Companies House register.
People and entities with significant control, from the Companies House PSC register
Figures from 2023 accounts. Newer accounts, made up to 30 June 2025, are filed but not read yet. See them on Companies House
| 2023 | |
|---|---|
| Fixed Assets | £53,963 |
| Current Assets | £581,309 |
| Creditors (< 1 year) | £270,865 |
| Net Current Assets | £311,920 |
| Net Assets | £226,827 |
| Shareholder Funds | £226,827 |
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 10 July 2026 | Accounts for a small company | 30 June 2025 | ||
| 5 January 2026 | Appointment of a director | |||
| 11 December 2025 | Confirmation statement with no updates | 1 December 2025 | ||
| 27 November 2025 | Termination of appointment of a director | |||
| 30 September 2025 | Appointment of a director |
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →